Squarepoint Ops LLC Regencell Bioscience Holdings LTD Transaction History
Squarepoint Ops LLC
- $96.1 Billion
- Q3 2025
A detailed history of Squarepoint Ops LLC transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Squarepoint Ops LLC holds 51,249 shares of RGC stock, worth $645,737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,249
Previous 99,843
48.67%
Holding current value
$645,737
Previous $1.7 Million
53.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RGC
# of Institutions
21Shares Held
625KCall Options Held
73.8KPut Options Held
105K-
Geode Capital Management, LLC Boston, MA420KShares$5.29 Million0.0% of portfolio
-
Discovery Capital Management, LLC South Norwalk, CT46.2KShares$581,6910.06% of portfolio
-
Xtx Topco LTD London, X038.7KShares$488,0610.03% of portfolio
-
Morgan Stanley New York, NY37.8KShares$476,8090.0% of portfolio
-
Vident Advisory, LLC Alpharetta, GA18.1KShares$227,6560.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $164M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...